世界の構造的心疾患治療機器市場2021年-2025年

◆英語タイトル:Global Structural Heart Disease Treatment Devices Market 2021-2025
◆商品コード:IRTNTR40733
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年3月10日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は世界の構造的心疾患治療機器市場規模が、2021年~2025年まで年平均8%成長し、49.3億ドルに達すると予測しています。本調査レポートでは、構造的心疾患治療機器の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(交換用機器、修理用機器)分析、エンドユーザー別(病院・診療所、外来手術センター)分析、顧客状況、地域別状況、企業状況、企業分析などを掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の構造的心疾患治療機器市場規模:製品別(交換用機器、修理用機器)
・世界の構造的心疾患治療機器市場規模:エンドユーザー別(病院・診療所、外来手術センター)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Structural Heart Disease Treatment Devices Market 2021-2025

Technavio has been monitoring the structural heart disease treatment devices market and it is poised to grow by $ 4.93 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our reports on structural heart disease treatment devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of structural heart diseases, rising number of new product launches, and growing number of M&A activities. In addition, increasing prevalence of structural heart diseases is anticipated to boost the growth of the market as well.

The structural heart disease treatment devices market analysis includes product segment, end-user segment and geographical landscapes.

Technavio’s structural heart disease treatment devices market is segmented as below:
By Product
• Replacement devices
• Repair devices

By End-user
• Hospitals and clinics
• ASCs

By Geographical Landscapes
• North America
• Europe
• APAC
• ROW

This study identifies the growing number of strategic alliances as one of the prime reasons driving the structural heart disease treatment devices market growth during the next few years. Also, strong clinical pipeline for heart valve devices and technological innovations in structural heart disease treatment will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on structural heart disease treatment devices market covers the following areas:
• Structural heart disease treatment devices market sizing
• Structural heart disease treatment devices market forecast
• Structural heart disease treatment devices market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading structural heart disease treatment devices market vendors that include Abbott Laboratories, Becton, Dickinson and Co., Boston Scientific Corp., Braile Biomédica, CryoLife Inc., Edwards Lifesciences Corp., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova Plc, Medtronic Plc, and MicroPort Scientific Corp.. Also, the structural heart disease treatment devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/.structural-heart-disease-treatment-devices-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Impact of COVID-19 on healthcare
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Replacement devices – Market size and forecast 2020-2025
o Repair devices – Market size and forecast 2020-2025
o Market opportunity by Product
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Hospitals and clinics – Market size and forecast 2020-2025
o ASCs – Market size and forecast 2020-2025
o Market opportunity by End-user
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o APAC – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Boston Scientific Corp.
o Braile Biomédica
o CryoLife Inc.
o Edwards Lifesciences Corp.
o Lepu Medical Technology (Beijing) Co. Ltd.
o LivaNova Plc
o Medtronic Plc
o MicroPort Scientific Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2020 – 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 – 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2020
• 22: Product – Market share 2020-2025 (%)
• 23: Comparison by Product
• 24: Replacement devices – Market size and forecast 2020-2025 ($ million)
• 25: Replacement devices – Year-over-year growth 2020-2025 (%)
• 26: Repair devices – Market size and forecast 2020-2025 ($ million)
• 27: Repair devices – Year-over-year growth 2020-2025 (%)
• 28: Market opportunity by Product
• 29: End user – Market share 2020-2025 (%)
• 30: Comparison by End user
• 31: Hospitals and clinics – Market size and forecast 2020-2025 ($ million)
• 32: Hospitals and clinics – Year-over-year growth 2020-2025 (%)
• 33: ASCs – Market size and forecast 2020-2025 ($ million)
• 34: ASCs – Year-over-year growth 2020-2025 (%)
• 35: Market opportunity by End user
• 36: Customer landscape
• 37: Market share by geography 2020-2025 (%)
• 38: Geographic comparison
• 39: North America – Market size and forecast 2020-2025 ($ million)
• 40: North America – Year-over-year growth 2020-2025 (%)
• 41: Europe – Market size and forecast 2020-2025 ($ million)
• 42: Europe – Year-over-year growth 2020-2025 (%)
• 43: APAC – Market size and forecast 2020-2025 ($ million)
• 44: APAC – Year-over-year growth 2020-2025 (%)
• 45: ROW – Market size and forecast 2020-2025 ($ million)
• 46: ROW – Year-over-year growth 2020-2025 (%)
• 47: Key leading countries
• 48: Market opportunity by geography ($ million)
• 49: Impact of drivers and challenges
• 50: Vendor landscape
• 51: Landscape disruption
• 52: Industry risks
• 53: Vendors covered
• 54: Market positioning of vendors
• 55: Abbott Laboratories – Overview
• 56: Abbott Laboratories – Business segments
• 57: Abbott Laboratories – Key offerings
• 58: Abbott Laboratories – Key customers
• 59: Abbott Laboratories – Segment focus
• 60: Becton, Dickinson and Co. – Overview
• 61: Becton, Dickinson and Co. – Business segments
• 62: Becton, Dickinson and Co. – Key offerings
• 63: Becton, Dickinson and Co. – Key customers
• 64: Becton, Dickinson and Co. – Segment focus
• 65: Boston Scientific Corp. – Overview
• 66: Boston Scientific Corp. – Business segments
• 67: Boston Scientific Corp. – Key offerings
• 68: Boston Scientific Corp. – Key customers
• 69: Boston Scientific Corp. – Segment focus
• 70: Braile Biomédica – Overview
• 71: Braile Biomédica – Product and service
• 72: Braile Biomédica – Key offerings
• 73: Braile Biomédica – Key customers
• 74: Braile Biomédica – Segment focus
• 75: CryoLife Inc. – Overview
• 76: CryoLife Inc. – Business segments
• 77: CryoLife Inc. – Key offerings
• 78: CryoLife Inc. – Key customers
• 79: CryoLife Inc. – Segment focus
• 80: Edwards Lifesciences Corp. – Overview
• 81: Edwards Lifesciences Corp. – Business segments
• 82: Edwards Lifesciences Corp. – Key offerings
• 83: Edwards Lifesciences Corp. – Key customers
• 84: Edwards Lifesciences Corp. – Segment focus
• 85: Lepu Medical Technology (Beijing) Co. Ltd. – Overview
• 86: Lepu Medical Technology (Beijing) Co. Ltd. – Product and service
• 87: Lepu Medical Technology (Beijing) Co. Ltd. – Key offerings
• 88: Lepu Medical Technology (Beijing) Co. Ltd. – Key customers
• 89: Lepu Medical Technology (Beijing) Co. Ltd. – Segment focus
• 90: LivaNova Plc – Overview
• 91: LivaNova Plc – Business segments
• 92: LivaNova Plc – Key offerings
• 93: LivaNova Plc – Key customers
• 94: LivaNova Plc – Segment focus
• 95: Medtronic Plc – Overview
• 96: Medtronic Plc – Business segments
• 97: Medtronic Plc – Key offerings
• 98: Medtronic Plc – Key customers
• 99: Medtronic Plc – Segment focus
• 100: MicroPort Scientific Corp. – Overview
• 101: MicroPort Scientific Corp. – Business segments
• 102: MicroPort Scientific Corp. – Key offerings
• 103: MicroPort Scientific Corp. – Key customers
• 104: MicroPort Scientific Corp. – Segment focus
• 105: Currency conversion rates for US$
• 106: Research Methodology
• 107: Validation techniques employed for market sizing
• 108: Information sources
• 109: List of abbreviations



【掲載企業】

Abbott Laboratories, Becton, Dickinson and Co., Boston Scientific Corp., Braile Biomédica, CryoLife Inc., Edwards Lifesciences Corp., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の構造的心疾患治療機器市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆